Zhuhai Guanyu: It was selected as the designated supplier of low-voltage lithium batteries for its 12V cars after being notified by domestic car companies. Zhuhai Guanyu announced that the company was recently notified by a domestic car company and was selected as the designated supplier of low-voltage lithium batteries for its 12V cars. This appointment will help to enhance the company's competitiveness and sustainable development ability in this field, and lay the foundation for future market share enhancement. At present, the company has been recognized by many well-known car companies, such as SAIC, Zhiji, Jaguar Land Rover, Stellantis, GM, etc., and has obtained a number of vehicle project designation letters. However, the fixed-point notice is not the final supply agreement, and the project needs to go through many links from fixed-point to mass production, so it is uncertain whether the order can be obtained in the end.The Bank of Italy said that the economy may only grow by 0.5% this year, and the Bank of Italy said in a statement on Friday that the gross domestic product (GDP) will increase by 0.5% in 2024. If seasonal and calendar effects are not taken into account, this figure will increase to 0.7%, but it is lower than the government's estimate of 1% in the budget. In addition, GDP growth is expected to be 0.8% in 2025 and 1.1% in 2026. It is estimated that the unified average inflation rate in the EU will be 1.1% in 2024, which is the same as the estimated value in October, 1.5% in 2025 and 1.6% in 2025.Governor of Poland's central bank: Poland will continue to achieve the CPI target.
Market news: South Korean court issued an arrest warrant to Seoul police chief.State-owned Assets Supervision and Administration Commission (SASAC): Actively expand effective investment, improve investment efficiency, and focus on the layout of a number of major projects with strong traction and long-term benefits. The Party Committee of the State Council SASAC held a special meeting. The meeting stressed that it is necessary to promote central enterprises to improve their ability to cope with cyclical fluctuations, continue to exert efforts in performance appraisal, quality improvement and efficiency improvement, and economic operation, and strive to simultaneously improve efficiency and efficiency indicators, and strive to achieve development with stronger scientific and technological attributes and greater driving role; Actively expand effective investment, improve investment efficiency, focus on "two" and "two new" layout of a number of major projects with strong traction and long-term benefits; We will do a better job in helping small and medium-sized enterprises, promote central enterprises to deepen strategic cooperation in the industrial chain, take the lead in paying off debts owed by private enterprises, and go all out to stabilize employment, supply and flow, so as to better help the national economy continue to pick up. It is necessary to promote the central enterprises to improve the supply capacity of common technologies, further highlight the key points and strengthen the key core technologies, especially in areas with large investment and long cycle; Further highlight the original innovation, explore and create a "policy enclave", strengthen the applied basic research, and deeply root the "root technology"; Further highlight the transformation of achievements, promote the construction of a number of major pilot projects by central enterprises, and constantly open up the "last mile" of the transformation of scientific and technological achievements into real productive forces, so as to better help high-level science and technology stand on its own feet. (SASAC)Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.
The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.State-owned Assets Supervision and Administration Commission (SASAC): Actively expand effective investment, improve investment efficiency, and focus on the layout of a number of major projects with strong traction and long-term benefits. The Party Committee of the State Council SASAC held a special meeting. The meeting stressed that it is necessary to promote central enterprises to improve their ability to cope with cyclical fluctuations, continue to exert efforts in performance appraisal, quality improvement and efficiency improvement, and economic operation, and strive to simultaneously improve efficiency and efficiency indicators, and strive to achieve development with stronger scientific and technological attributes and greater driving role; Actively expand effective investment, improve investment efficiency, focus on "two" and "two new" layout of a number of major projects with strong traction and long-term benefits; We will do a better job in helping small and medium-sized enterprises, promote central enterprises to deepen strategic cooperation in the industrial chain, take the lead in paying off debts owed by private enterprises, and go all out to stabilize employment, supply and flow, so as to better help the national economy continue to pick up. It is necessary to promote the central enterprises to improve the supply capacity of common technologies, further highlight the key points and strengthen the key core technologies, especially in areas with large investment and long cycle; Further highlight the original innovation, explore and create a "policy enclave", strengthen the applied basic research, and deeply root the "root technology"; Further highlight the transformation of achievements, promote the construction of a number of major pilot projects by central enterprises, and constantly open up the "last mile" of the transformation of scientific and technological achievements into real productive forces, so as to better help high-level science and technology stand on its own feet. (SASAC)Huawang Technology: Zhang Yancheng, the director, plans to reduce the company's shares by no more than 0.3443%. Huawang Technology announced that Zhang Yancheng, the company's director and senior manager, plans to reduce the company's shares by no more than 1.6 million shares through centralized bidding on the Shanghai Stock Exchange within three months after the announcement date, accounting for 0.3443% of the company's total share capital. The reduction price will be determined according to the market price. Zhang Yancheng currently holds 6,671,700 shares of the company, accounting for 1.4357% of the company's total share capital.
Strategy guide 12-14
Strategy guide 12-14